India approves Zydus' DNA-based three-dose Covid vaccine for emergency use
Adolescents in the age group of 12-18 years can take the shot in India20-08-2021
20-08-2021
Zydus completes pragmatic trials' for second vax
ZyCoV-MV likely to provide lasting immunity11-08-2021
Zydus Wellness Ltd - 531335 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of participation in investor call on August 13, 2021.10-08-2021
ZYDUS WELLNESS LTD.-$ - 531335 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of details of duplicate certificate under regulation 39(3) of SEBI LODR.09-08-2021
Zydus Wellness Ltd - 531335 - Transcript Of 27Th Annual General Meeting Of The Company Held On July 30, 2021.
Transcript of 27th Annual General Meeting of the Company held on July 30, 2021.03-08-2021
ZYDUS WELLNESS LTD.-$ - 531335 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Announcement under Regulation 30 (LODR) - Earnings call Transcript.02-08-2021
ZYDUS WELLNESS LTD.-$ - 531335 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication of unaudited results for the quarter ended on June 30, 2021.31-07-2021
Zydus Wellness Ltd - 531335 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Zydus Wellness Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here31-07-2021
Zydus Wellness Ltd - 531335 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Proceedings of 27th Annual General Meeting of the Company held on July 30, 2021.30-07-2021
Zydus Wellness Ltd - 531335 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Regulation 44(3) Voting Results AGM Held On July 30, 2021.30-07-2021